Kedaara Capital

Premium
Carlyle weighs possible bid for south India bulk-drugs firm

Healthcare

18 September, 2020

Carlyle weighs possible bid for south India bulk-drugs firm

Private equity firm The Carlyle Group is evaluating a Hyderabad-based bulk-drugs maker as part of its plan to build an ......

Premium

Finance

01 September, 2020

Partners Group makes spectacular partial exit from Indian lender

Partners Group, a Switzerland-based private markets investment management firm, has generated stellar returns by divesting a part...

Premium

Healthcare

28 August, 2020

PAG joins Indian PE firms for pharma platform, eyes second deal

Hong Kong-based alternative investment firm PAG Asia Capital has joined two Indian private equity firms to build a bulk-drugs...

Premium

Finance

03 June, 2020

Kedaara Capital opts for bigger stake in health insurance bet

Homegrown private equity firm Kedaara Capital has made a bigger bet on a healthcare insurance company than what was earlier ......

Premium

Finance

15 May, 2020

Sarva Capital scores multi-bagger exit from non-bank lender

Venture capital fund Sarva Capital has made a multi-bagger exit from its five-year-old investment in a non-banking finance company...

Premium

Finance

17 April, 2020

Bank mergers keep financial sector in focus but PE deals slip again in Jan-March

India’s banking, financial services and insurance (BFSI) sector recorded seven big mergers in the first quarter of 2020...

Premium

Finance

13 April, 2020

Fund Scan: Can Kedaara Capital stay the course as coronavirus shakes portfolio firms?

Last month, private equity firm Kedaara Capital added a non-bank lender to its portfolio. At any other time the investment ......

Premium

Finance

17 March, 2020

How the rupee's slide after the virus outbreak may hurt PE, VC firms

Ever since the coronavirus outbreak became a global pandemic, world markets have been in turmoil. The pandemic, which has already...

Premium

Healthcare

12 February, 2020

Kedaara Capital backs Gujarat life sciences firm in first pharma bet

Homegrown private equity firm Kedaara Capital has made its first pharmaceuticals bet with an investment in a bulk-drugs maker...

Premium

Finance

07 February, 2020

Kedaara makes spectacular returns from another partial exit in mortgage lender

Homegrown private equity firm Kedaara Capital has sold part of its stake in a housing finance company it had backed ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News